New Lawsuits Accuse GSK of Marketing Zofran as Morning Sickness Remedy While Hiding Risk of Birth Defects

BOSTON - Two women have sued GlaxoSmithKline in Massachusetts and Texas federal courts, accusing the drug maker of fraudulently marketing its anti-nausea drug Zofran as an off-label morning sickness remedy while concealing the risk that ingestion of the drug by pregnant women can cause serious birth defects.

In an April 17 complaint filed in the U.S. District Court for the District of Massachusetts, plaintiff Kim Duong alleges that taking Zofran while pregnant caused her unborn baby to develop severe and life-threatening fetal defects, forcing her to terminate the pregnancy.

In a similar complaint filed the same day in the U.S. …